Global Continuous Subcutaneous Insulin Infusion Devices Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Continuous Subcutaneous Insulin Infusion Devices by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Continuous Subcutaneous Insulin Infusion Devices by Country/Region, 2017, 2022 & 2028

2.2 Continuous Subcutaneous Insulin Infusion Devices Segment by Type

2.2.1 Normal Pump

2.2.2 Patch Pump

2.3 Continuous Subcutaneous Insulin Infusion Devices Sales by Type

2.3.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2017-2022)

2.3.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue and Market Share by Type (2017-2022)

2.3.3 Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Type (2017-2022)

2.4 Continuous Subcutaneous Insulin Infusion Devices Segment by Application

2.4.1 Type I Diabetes

2.4.2 Type II Diabetes

2.5 Continuous Subcutaneous Insulin Infusion Devices Sales by Application

2.5.1 Global Continuous Subcutaneous Insulin Infusion Devices Sale Market Share by Application (2017-2022)

2.5.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue and Market Share by Application (2017-2022)

2.5.3 Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Application (2017-2022)

3 Global Continuous Subcutaneous Insulin Infusion Devices by Company

3.1 Global Continuous Subcutaneous Insulin Infusion Devices Breakdown Data by Company

3.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Annual Sales by Company (2020-2022)

3.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Company (2020-2022)

3.2 Global Continuous Subcutaneous Insulin Infusion Devices Annual Revenue by Company (2020-2022)

3.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Company (2020-2022)

3.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Company (2020-2022)

3.3 Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Company

3.4 Key Manufacturers Continuous Subcutaneous Insulin Infusion Devices Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Continuous Subcutaneous Insulin Infusion Devices Product Location Distribution

3.4.2 Players Continuous Subcutaneous Insulin Infusion Devices Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Continuous Subcutaneous Insulin Infusion Devices by Geographic Region

4.1 World Historic Continuous Subcutaneous Insulin Infusion Devices Market Size by Geographic Region (2017-2022)

4.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Annual Revenue by Geographic Region

4.2 World Historic Continuous Subcutaneous Insulin Infusion Devices Market Size by Country/Region (2017-2022)

4.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Annual Sales by Country/Region (2017-2022)

4.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Annual Revenue by Country/Region

4.3 Americas Continuous Subcutaneous Insulin Infusion Devices Sales Growth

4.4 APAC Continuous Subcutaneous Insulin Infusion Devices Sales Growth

4.5 Europe Continuous Subcutaneous Insulin Infusion Devices Sales Growth

4.6 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Growth

5 Americas

5.1 Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Country

5.1.1 Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2017-2022)

5.1.2 Americas Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2017-2022)

5.2 Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Type

5.3 Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Region

6.1.1 APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2017-2022)

6.1.2 APAC Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2017-2022)

6.2 APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Type

6.3 APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Continuous Subcutaneous Insulin Infusion Devices by Country

7.1.1 Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2017-2022)

7.1.2 Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2017-2022)

7.2 Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Type

7.3 Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices by Country

8.1.1 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2017-2022)

8.1.2 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2017-2022)

8.2 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Type

8.3 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Continuous Subcutaneous Insulin Infusion Devices

10.3 Manufacturing Process Analysis of Continuous Subcutaneous Insulin Infusion Devices

10.4 Industry Chain Structure of Continuous Subcutaneous Insulin Infusion Devices

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Continuous Subcutaneous Insulin Infusion Devices Distributors

11.3 Continuous Subcutaneous Insulin Infusion Devices Customer

12 World Forecast Review for Continuous Subcutaneous Insulin Infusion Devices by Geographic Region

12.1 Global Continuous Subcutaneous Insulin Infusion Devices Market Size Forecast by Region

12.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Forecast by Region (2023-2028)

12.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Continuous Subcutaneous Insulin Infusion Devices Forecast by Type

12.7 Global Continuous Subcutaneous Insulin Infusion Devices Forecast by Application

13 Key Players Analysis

13.1 Medtronic

13.1.1 Medtronic Company Information

13.1.2 Medtronic Continuous Subcutaneous Insulin Infusion Devices Product Offered

13.1.3 Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Medtronic Main Business Overview

13.1.5 Medtronic Latest Developments

13.2 Roche

13.2.1 Roche Company Information

13.2.2 Roche Continuous Subcutaneous Insulin Infusion Devices Product Offered

13.2.3 Roche Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Roche Main Business Overview

13.2.5 Roche Latest Developments

13.3 Insulet Corp

13.3.1 Insulet Corp Company Information

13.3.2 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product Offered

13.3.3 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Insulet Corp Main Business Overview

13.3.5 Insulet Corp Latest Developments

13.4 Tandem Diabetes care

13.4.1 Tandem Diabetes care Company Information

13.4.2 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product Offered

13.4.3 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Tandem Diabetes care Main Business Overview

13.4.5 Tandem Diabetes care Latest Developments

13.5 Valeritas

13.5.1 Valeritas Company Information

13.5.2 Valeritas Continuous Subcutaneous Insulin Infusion Devices Product Offered

13.5.3 Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Valeritas Main Business Overview

13.5.5 Valeritas Latest Developments

13.6 SOOIL

13.6.1 SOOIL Company Information

13.6.2 SOOIL Continuous Subcutaneous Insulin Infusion Devices Product Offered

13.6.3 SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 SOOIL Main Business Overview

13.6.5 SOOIL Latest Developments

13.7 Microport

13.7.1 Microport Company Information

13.7.2 Microport Continuous Subcutaneous Insulin Infusion Devices Product Offered

13.7.3 Microport Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Microport Main Business Overview

13.7.5 Microport Latest Developments

14 Research Findings and Conclusion

Table 1. Continuous Subcutaneous Insulin Infusion Devices Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Continuous Subcutaneous Insulin Infusion Devices Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Normal Pump

Table 4. Major Players of Patch Pump

Table 5. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2017-2022) & (K Units)

Table 6. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2017-2022)

Table 7. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Type (2017-2022) & ($ million)

Table 8. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Type (2017-2022)

Table 9. Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2017-2022) & (K Units)

Table 11. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2017-2022)

Table 12. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Application (2017-2022)

Table 13. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Application (2017-2022)

Table 14. Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Company (2020-2022) & (K Units)

Table 16. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Company (2020-2022)

Table 17. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Company (2020-2022)

Table 19. Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Continuous Subcutaneous Insulin Infusion Devices Producing Area Distribution and Sales Area

Table 21. Players Continuous Subcutaneous Insulin Infusion Devices Products Offered

Table 22. Continuous Subcutaneous Insulin Infusion Devices Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share Geographic Region (2017-2022)

Table 27. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country/Region (2017-2022)

Table 31. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2017-2022) & (K Units)

Table 34. Americas Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2017-2022)

Table 35. Americas Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2017-2022)

Table 37. Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2017-2022) & (K Units)

Table 38. Americas Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2017-2022)

Table 39. Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2017-2022) & (K Units)

Table 40. Americas Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2017-2022)

Table 41. APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2017-2022) & (K Units)

Table 42. APAC Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region (2017-2022)

Table 43. APAC Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Region (2017-2022)

Table 45. APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2017-2022) & (K Units)

Table 46. APAC Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2017-2022)

Table 47. APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2017-2022) & (K Units)

Table 48. APAC Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2017-2022)

Table 49. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2017-2022) & (K Units)

Table 50. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2017-2022)

Table 51. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2017-2022)

Table 53. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2017-2022) & (K Units)

Table 54. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2017-2022)

Table 55. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2017-2022) & (K Units)

Table 56. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Continuous Subcutaneous Insulin Infusion Devices

Table 66. Key Market Challenges & Risks of Continuous Subcutaneous Insulin Infusion Devices

Table 67. Key Industry Trends of Continuous Subcutaneous Insulin Infusion Devices

Table 68. Continuous Subcutaneous Insulin Infusion Devices Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Continuous Subcutaneous Insulin Infusion Devices Distributors List

Table 71. Continuous Subcutaneous Insulin Infusion Devices Customer List

Table 72. Global Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Forecast by Region

Table 74. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share Forecast by Application (2023-2028)

Table 92. Medtronic Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors

Table 93. Medtronic Continuous Subcutaneous Insulin Infusion Devices Product Offered

Table 94. Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Medtronic Main Business

Table 96. Medtronic Latest Developments

Table 97. Roche Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors

Table 98. Roche Continuous Subcutaneous Insulin Infusion Devices Product Offered

Table 99. Roche Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Roche Main Business

Table 101. Roche Latest Developments

Table 102. Insulet Corp Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors

Table 103. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product Offered

Table 104. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Insulet Corp Main Business

Table 106. Insulet Corp Latest Developments

Table 107. Tandem Diabetes care Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors

Table 108. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product Offered

Table 109. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Tandem Diabetes care Main Business

Table 111. Tandem Diabetes care Latest Developments

Table 112. Valeritas Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors

Table 113. Valeritas Continuous Subcutaneous Insulin Infusion Devices Product Offered

Table 114. Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Valeritas Main Business

Table 116. Valeritas Latest Developments

Table 117. SOOIL Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors

Table 118. SOOIL Continuous Subcutaneous Insulin Infusion Devices Product Offered

Table 119. SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. SOOIL Main Business

Table 121. SOOIL Latest Developments

Table 122. Microport Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors

Table 123. Microport Continuous Subcutaneous Insulin Infusion Devices Product Offered

Table 124. Microport Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Microport Main Business

Table 126. Microport Latest Developments

List of Figures

Figure 1. Picture of Continuous Subcutaneous Insulin Infusion Devices

Figure 2. Continuous Subcutaneous Insulin Infusion Devices Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Continuous Subcutaneous Insulin Infusion Devices Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Normal Pump

Figure 10. Product Picture of Patch Pump

Figure 11. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type in 2021

Figure 12. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Type (2017-2022)

Figure 13. Continuous Subcutaneous Insulin Infusion Devices Consumed in Type I Diabetes

Figure 14. Global Continuous Subcutaneous Insulin Infusion Devices Market: Type I Diabetes (2017-2022) & (K Units)

Figure 15. Continuous Subcutaneous Insulin Infusion Devices Consumed in Type II Diabetes

Figure 16. Global Continuous Subcutaneous Insulin Infusion Devices Market: Type II Diabetes (2017-2022) & (K Units)

Figure 17. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2017-2022)

Figure 18. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Application in 2021

Figure 19. Continuous Subcutaneous Insulin Infusion Devices Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Company in 2021

Figure 21. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Geographic Region in 2021

Figure 23. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region (2017-2022)

Figure 24. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country/Region in 2021

Figure 25. Americas Continuous Subcutaneous Insulin Infusion Devices Sales 2017-2022 (K Units)

Figure 26. Americas Continuous Subcutaneous Insulin Infusion Devices Revenue 2017-2022 ($ Millions)

Figure 27. APAC Continuous Subcutaneous Insulin Infusion Devices Sales 2017-2022 (K Units)

Figure 28. APAC Continuous Subcutaneous Insulin Infusion Devices Revenue 2017-2022 ($ Millions)

Figure 29. Europe Continuous Subcutaneous Insulin Infusion Devices Sales 2017-2022 (K Units)

Figure 30. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue 2017-2022 ($ Millions)

Figure 33. Americas Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country in 2021

Figure 34. Americas Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country in 2021

Figure 35. United States Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region in 2021

Figure 40. APAC Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Regions in 2021

Figure 41. China Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country in 2021

Figure 48. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country in 2021

Figure 49. Germany Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country in 2021

Figure 56. Egypt Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Continuous Subcutaneous Insulin Infusion Devices in 2021

Figure 62. Manufacturing Process Analysis of Continuous Subcutaneous Insulin Infusion Devices

Figure 63. Industry Chain Structure of Continuous Subcutaneous Insulin Infusion Devices

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles